Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


Articles published in Histopathology

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    February 2021
  1. ALATAKI A, Zabaglo L, Tovey H, Dodson A, et al
    A simple digital image analysis for automated Ki67 assessment in primary breast cancer.
    Histopathology. 2021 Feb 15. doi: 10.1111/his.14355.
    PubMed     Abstract available


  2. ELSHARAWY KA, Gerds TA, Rakha EA, Dalton LW, et al
    Artificial intelligence grading of breast cancer: a promising method to refine prognostic classification for management precision.
    Histopathology. 2021 Feb 15. doi: 10.1111/his.14354.
    PubMed     Abstract available


    January 2021
  3. BADR NM, Spooner D, Steven J, Stevens A, et al
    Morphological and molecular changes following neoadjuvant endocrine therapy of ER positive breast cancer: implications for clinical practice.
    Histopathology. 2021 Jan 10. doi: 10.1111/his.14331.
    PubMed     Abstract available


  4. TIEN TZ, Lee JNLW, Lim JCT, Chen XY, et al
    Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence (mIHC/IF).
    Histopathology. 2021 Jan 5. doi: 10.1111/his.14328.
    PubMed     Abstract available


    September 2020
  5. NOSKE A, Ammann JU, Wagner DC, Denkert C, et al
    A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays for scoring in triple-negative breast cancer.
    Histopathology. 2020 Sep 16. doi: 10.1111/his.14254.
    PubMed     Abstract available


    July 2020
  6. RAKHA EA, Alsaleem M, ElSharawy KA, Toss MS, et al
    Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morpho-molecular study.
    Histopathology. 2020 Jul 2. doi: 10.1111/his.14199.
    PubMed     Abstract available


  7. BERBEN L, Wildiers H, Marcelis L, Antoranz A, et al
    Computerised scoring protocol for identification and quantification of different immune cell populations in breast tumour regions by the use of QuPath software.
    Histopathology. 2020;77:79-91.
    PubMed     Abstract available


    June 2020
  8. HIDA AI, Omanovic D, Pedersen L, Oshiro Y, et al
    Automated assessment of Ki-67 in breast cancer: the utility of digital image analysis using virtual triple staining and whole slide imaging.
    Histopathology. 2020 Jun 24. doi: 10.1111/his.14140.
    PubMed     Abstract available


  9. VAN STEENHOVEN JEC, Kuijer A, Kornegoor R, van Leeuwen AM, et al
    Assessment of Tumour Proliferation by Mitotic Activity Index, Ki67 and Phosphohistone H3 in Early stage Luminal Breast Cancer.
    Histopathology. 2020 Jun 17. doi: 10.1111/his.14185.
    PubMed     Abstract available


  10. WILLIAMS B, Hanby A, Millican-Slater R, Verghese E, et al
    Digital pathology for primary diagnosis of screen-detected breast lesions - experimental data, validation and experience from four centres.
    Histopathology. 2020;76:968-975.
    PubMed     Abstract available


    May 2020
  11. ALTHOBITI M, El Ansari R, Aleskandarany M, Joseph C, et al
    The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
    Histopathology. 2020 May 5. doi: 10.1111/his.14129.
    PubMed     Abstract available


  12. PAREJA F, Toss MS, Geyer FC, da Silva EM, et al
    Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomas.
    Histopathology. 2020;76:865-874.
    PubMed     Abstract available


  13. THIKE AA, Chen X, Koh VCY, Binte Md Nasir ND, et al
    Higher densities of tumour-infiltrating lymphocytes and CD4(+) T cells predict recurrence and progression of ductal carcinoma in situ of the breast.
    Histopathology. 2020;76:852-864.
    PubMed     Abstract available


    April 2020
  14. PARK MH, Kwon SY, Choi JE, Gong G, et al
    Intratumoral CD103-positive tumor-infiltrating lymphocytes are associated with favorable prognosis in patients with triple-negative breast cancer.
    Histopathology. 2020 Apr 25. doi: 10.1111/his.14126.
    PubMed     Abstract available


  15. JAMIDI SK, Hu J, Aphivatanasiri C, Tsang JY, et al
    SOX10 as a sensitive marker for triple negative breast cancer.
    Histopathology. 2020 Apr 18. doi: 10.1111/his.14118.
    PubMed     Abstract available


  16. WILSHER MJ, Desai AJ, Pinder SE
    Low-grade adenosquamous carcinoma arising in association with a nipple adenoma.
    Histopathology. 2020;76:784-787.
    PubMed    


    March 2020
  17. AKASHI M, Yamaguchi R, Kusano H, Obara H, et al
    Diverse histomorphology of HER2-positive breast carcinomas based on differential ER expression.
    Histopathology. 2020;76:560-571.
    PubMed     Abstract available


    January 2020
  18. JANKOVIC-KARASOULOS T, Bianco-Miotto T, Butler MS, Butler LM, et al
    Elevated levels of tumor apolipoprotein-D independently predict poor outcome in breast cancer patients.
    Histopathology. 2020 Jan 28. doi: 10.1111/his.14081.
    PubMed     Abstract available


  19. SHOLL LM
    Programmed death ligand 1 immunohistochemistry: can we agree on this?
    Histopathology. 2020;76:189-190.
    PubMed    


    December 2019
  20. ARISPE ANGULO KR, Jawa Z, Visotcky A, Majidi SS, et al
    High Mitotic Score in Breast Cancer after Neoadjuvant Chemotherapy is Predictive of Outcome and Associated with a Distinct Morphology.
    Histopathology. 2019 Dec 17. doi: 10.1111/his.14049.
    PubMed     Abstract available


  21. FINSTERBUSCH K, Decker T, van Diest PJ, Focke CM, et al
    Luminal A versus B breast cancer: MammaTyper(R) mRNA versus immunohistochemical subtyping with emphasis on standardised Ki67-Labelling or Mitotic Activity Index based proliferation assessment.
    Histopathology. 2019 Dec 17. doi: 10.1111/his.14048.
    PubMed     Abstract available


    November 2019
  22. ELSHARAWY KA, Toss MS, Abuelmaaty SR, Ball G, et al
    Prognostic Significance of Nucleolar Assessment in Invasive Breast Cancer.
    Histopathology. 2019 Nov 17. doi: 10.1111/his.14036.
    PubMed     Abstract available


    July 2019
  23. EIRO N, Cid S, Fernandez B, Fraile M, et al
    MMP11 expression in intratumoral inflammatory cells in breast cancer.
    Histopathology. 2019 Jul 25. doi: 10.1111/his.13956.
    PubMed     Abstract available


    June 2019
  24. DOWNES MR, Slodkowska E, Katabi N, Jungbluth AA, et al
    Interobserver and Intraobserver agreement of PD-L1 scoring in Head and Neck Squamous Cell Carcinoma (HSCC), Urothelial Carcinoma (UC), and Breast Carcinoma (BC).
    Histopathology. 2019 Jun 27. doi: 10.1111/his.13946.
    PubMed     Abstract available


    April 2019
  25. LEUNG SCY, Nielsen TO, Zabaglo LA, Arun I, et al
    Analytical validation of a standardized scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicenter collaboration.
    Histopathology. 2019 Apr 24. doi: 10.1111/his.13880.
    PubMed     Abstract available


    March 2019
  26. LI J, Ho WY, Tsang JYS, Ni YB, et al
    Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breast.
    Histopathology. 2019;74:567-577.
    PubMed     Abstract available


    January 2019
  27. PEKAR G, Kasselaki I, Pekar-Lukacs A, Dekany C, et al
    Equivocal (HER2 IHC 2+) breast carcinomas: gene-protein assay testing reveals association between genetic heterogeneity, individual cell amplification status and potential treatment benefits.
    Histopathology. 2019;74:300-310.
    PubMed     Abstract available


  28. XU X, Bi R, Shui R, Yu B, et al
    Micropapillary pattern in pure mucinous carcinoma of the breast - does it matter or not?
    Histopathology. 2019;74:248-255.
    PubMed     Abstract available


    December 2018
  29. KOOPMAN T, Buikema HJ, Hollema H, de Bock GH, et al
    What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms.
    Histopathology. 2018 Dec 26. doi: 10.1111/his.13812.
    PubMed     Abstract available


  30. TSAI YF, Tseng LM, Lien PJ, Hsu CY, et al
    HER2 immunohistochemical scores provide prognostic information for patients with HER2-type invasive breast cancer.
    Histopathology. 2018 Dec 4. doi: 10.1111/his.13801.
    PubMed     Abstract available


    September 2018
  31. DEN BAKKER MA, Damhuis RAM
    Pentameric last-digit preference and stage border avoidance in pathology measurement.
    Histopathology. 2018;73:510-513.
    PubMed     Abstract available


    August 2018
  32. LOZADA JR, Basili T, Pareja F, Alemar B, et al
    Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.
    Histopathology. 2018;73:339-344.
    PubMed     Abstract available


  33. BATAILLON G, Fuhrmann L, Girard E, Menet E, et al
    High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breast.
    Histopathology. 2018;73:273-283.
    PubMed     Abstract available


    July 2018
  34. UMEKITA Y, Ohi Y, Iwaya O, Souda M, et al
    Maspin mRNA expression in sentinel lymph nodes (SLNs) predicts non-SLN metastasis in breast cancer patients with SLN metastasis.
    Histopathology. 2018 Jul 23. doi: 10.1111/his.13718.
    PubMed     Abstract available


  35. RAKHA EA, Aleskandarany MA, Toss MS, Mongan N, et al
    Impact of Breast Cancer Grade Discordance on Prediction of Outcome.
    Histopathology. 2018 Jul 12. doi: 10.1111/his.13709.
    PubMed     Abstract available


  36. CAO L, Li C, Xu C, Xiang G, et al
    Clinical significance of PDEF factor expression and its relation to androgen receptor in ER(-) breast cancer.
    Histopathology. 2018 Jul 3. doi: 10.1111/his.13699.
    PubMed     Abstract available


  37. RAGHAVENDRA A, Kalita-de Croft P, Vargas AC, Smart CE, et al
    Expression of MAGE-A and NY-ESO-1 cancer/testis antigens is enriched in triple-negative invasive breast cancers.
    Histopathology. 2018;73:68-80.
    PubMed     Abstract available


    June 2018
  38. ALTHOBITI M, Aleskandarany MA, Joseph C, Toss M, et al
    Heterogeneity of Tumour Infiltrating Lymphocytes (TILs) in Breast Cancer and its prognostic significance.
    Histopathology. 2018 Jun 27. doi: 10.1111/his.13695.
    PubMed     Abstract available


  39. PUCCETTI M, Ravaioli S, Tumedei MM, Bucchi E, et al
    Are FNAB-derived cell blocks a useful surrogate for tissue samples in breast cancer?
    Histopathology. 2018 Jun 26. doi: 10.1111/his.13694.
    PubMed     Abstract available


  40. RAKHA EA, Miligy IM, Gorringe KL, Toss MS, et al
    Invasion in breast lesions: the role of the epithelial-stroma barrier.
    Histopathology. 2018;72:1075-1083.
    PubMed     Abstract available


    May 2018
  41. AFFLECK A, Lyman WB, Jacobs WC, Livasy CA, et al
    Metastatic breast cancer to the liver with hepatoid features and Hep Par 1 antibody positive mimicking hepatocellular carcinoma.
    Histopathology. 2018 May 9. doi: 10.1111/his.13644.
    PubMed     Abstract available


  42. JOSEPH C, Papadaki A, Althobiti M, Alsaleem M, et al
    Breast cancer intra-tumour heterogeneity: Current status and clinical implications.
    Histopathology. 2018 May 2. doi: 10.1111/his.13642.
    PubMed     Abstract available


    March 2018
  43. ALFARSI L, Johnston S, Liu DX, Rakha E, et al
    Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer.
    Histopathology. 2018 Mar 30. doi: 10.1111/his.13523.
    PubMed     Abstract available


  44. BULTE JP, Halilovic A, Kalkman S, van Cleef PHJ, et al
    Assessment of HER2 status in breast cancer biopsies is not affected by accelerated tissue processing.
    Histopathology. 2018 Mar 1. doi: 10.1111/his.13507.
    PubMed     Abstract available


    December 2017
  45. STALHAMMAR G, Robertson S, Wedlund L, Lippert M, et al
    Digital image analysis of Ki67 in hot spots is superior to both manual Ki67 and mitotic counts in breast cancer.
    Histopathology. 2017 Dec 8. doi: 10.1111/his.13452.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: